Attorney's Letter UpDate October 2nd/3rd, 2021
OTC Markets Group, Inc.
300 Vesey Street, 12th Floor
New York, NY 10282
Re: Legal Opinion, Adequate Current Information, Continuing Disclosure Obligations of
JPX Global , Inc., a Nevada corporation (the “Issuer”) for the Annual Reports for Periods
Ending 12/31/2019 and 12/31/2020, and the Quarterly Reports for the Period Ending
03/31/2021 and 6/30/2021.
Ladies and Gentlemen:
This office has been engaged by JPX Global, Inc., a Nevada corporation, (the "Issuer"
as its
general and securities counsel for matters including, but not limited to, the preparation of this
opinion.
This opinion may be posted on the OTC Disclosure and News Service for viewing by the general
public. OTC Markets Group, Inc. may rely on this opinion in determining whether the Issuer has
made adequate current information publicly available within the meaning of Rule 144(c)(2) of
the Securities Act of 1933, as amended.
This letter covers the laws of the United States and does not depend on another law firm’s
opinion or letter. The subject matter of this letter covers the jurisdiction of the State of Nevada
(the Issuer's state of incorporation) and the laws of the United States. Attorney Udo Ekekeulu
(hereinafter referred to as Counsel) is permitted to practice before the Securities and Exchange
Commission without prohibition. Counsel is licensed in the State of California and is a resident
of the State of California. Counsel is current in her membership requirements for the State of
California. Counsel is currently not, and has not within the past five years, been the subject of an
investigation, hearing, or proceeding by the SEC, the US Commodity Futures Trading
Commission, (CFTC), the Financial Industry Regulatory Authority, (FINRA) or any other
federal, state, or foreign regulatory agency. Counsel is also currently not, and has not within the
past five years, been suspended or barred from practicing in any jurisdiction. She has not been
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 2 of 7
charged in a civil or criminal case. A representative of the Company is responsible for the
preparation of the financial statements in accordance with GAAP, under the supervision of the
CEO and is unaudited.
Counsel is not an employee of the Issuer and Counsel has received no shares of the Issuer’s stock
in payment for Counsel’s services. Furthermore, Counsel does not have any current agreements
to receive, whether now or in the future, any shares of Issuer common stock as compensation for
preparation of this opinion or for any other services. Counsel does not own, directly or
beneficially, any shares of the Issuer’s Securities.
Counsel has been retained by the Issuer for the purpose of reviewing the current information
supplied by the Issuer and has also been retained as outside counsel for other matters. Counsel
has examined such corporate records and other documents and such questions of law as counsel
considers necessary or appropriate for the purposes of rendering this letter.
For purposes of this opinion counsel has reviewed the
1. Articles of Incorporation and Amendments of the Articles of Incorporation of the Issuer,
2. Corporate By-Laws,
3. Information, as defined below
4. And such other corporate records as were necessary and provided by management for
purposes of this letter, including press releases and past and current financial statements and
have examined such corporate records and other documents and such questions of law as counsel
considered necessary or appropriate for purposes of rendering the letter.
We have (i) personally interviewed via phone conference the management and all directors of the
Company, more specifically Ambrose O Egbuonu, CEO, President, Treasurer, the CourtAppointed Custodian, Frank I Igwealor, and all owners of 5% or greater of the outstanding stock
including Frank I Igwealor, however, we’re not able to contact, meet or interview persons who
were associated with prior management (this shell was purchased from a custodial management),
(ii) reviewed the annual financials ended December 31, 2020 and filed with the OTC disclosure
News Service on www.OTCmarkets.com and posted on October 02, 2021, reviewed the annual
financials ended December 31, 2019 and filed with the OTC disclosure News Service on
www.OTCmarkets.com and posted on October 02, 2021, reviewed the quarterly financials ended
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 3 of 7
March 31, 2021 and filed with the OTC disclosure News Service on www.OTCmarkets.com and
posted on October 02, 2021, reviewed the quarterly financials ended June 30, 2021 and filed with
the OTC disclosure News Service on www.OTCmarkets.com and posted on October 02, 2021,
and (iii) discussed the information with management and the director(s) of the Company.
To the best of our knowledge, after inquiry of management, including the sole Chief Executive
Officer and Director, neither the Issuer, the 5% holders of securities of the Company, nor the
corporate counsel are currently under investigation by any federal or state regulatory authority
for any violation of federal or state securities laws. There are no other family relationships or
related party transactions with JPEX to disclose in its filings or in the Attorney letter. The
company has not received any request for information or inquiries of any kind from the SEC or
FINRA and are unaware of any request or inquiries from the SEC or FINRA since January 31,
2018. There are no pending corporate actions.
The opinion and conclusions herein are based upon documentation and facts made available by
the Issuer and are based on the accuracy of those documents and facts. All such information is
believed to be true and such sources of information are believed to be reliable. As to matters of
fact, counsel relied on information obtained from public officials, officers of the Issuer and other
sources, and believed such information to be true and such sources of information are believed to
be reliable. If the facts and information in all such documents are determined not to be true, this
opinion shall be null and void.
We may rely on information obtained from public officials, officers of the Company and we
believe that these sources are reliable. In rendering this letter, we have examined the following:
1. Corporate records and other documents of the company.
Financial documents including: Balance Sheet, Statement of Operations, Statement of Cash
Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in
Shareholder Equity) and notes to the financial statements for the year ending December 31,
2020, uploaded to the OTC disclosure News Service on www.OTCmarkets.com and posted on
October 02, 2021; Balance Sheet, Statement of Operations, Statement of Cash Flows,
Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder
Equity) and notes to the financial statements for the year ending December 31, 2019, uploaded to
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 4 of 7
the OTC disclosure News Service on www.OTCmarkets.com and posted on October 02, 2021;
Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of
Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the
financial statements for the quarter ending March 31, 2021, uploaded to the OTC disclosure
News Service on www.OTCmarkets.com and posted on October 02, 2021; and Balance Sheet,
Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s
Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements
for the quarter ending June 30, 2021, uploaded to the OTC disclosure News Service on
www.OTCmarkets.com and posted on October 02, 2021. We may rely on information obtained
from public officials, officers of the Company and we believe that these sources are reliable.
2. Issuer’s financial statements are not audited. The person responsible for the preparation of the
financial
statements contained in the report for the annual periods identified herein is Ambrose O
Egbuonu, the Issuer’s CEO and President. Mr. Egbuonu was assisted in the preparation of the
Issuer’s financial statements by Mr. Frank I Igwealor, CPA, CMA, who has over twenty six
years of management accounting and finance or consulting experience with OTC companies
including more than fourteen years as senior management level such as CEO, CFO, Controller
and Manager of several public or OTC companies including experience preparing financial
reports for those public companies. His address is 370 Amapola Ave., Suite 200-A, Torrance,
CA 90501, Tel. 310-895-1839.
3. Representations made to us by the sole officer and director of the Company which we deem as
reliable.
4. Review of the Shareholders’ list provided by the Company’s transfer agent: Pacific Stock
Transfer Company of 6725 Via Austi Pkwy., Ste. 300, Las Vegas, NV 89119, Tel. 702-581-
8475, indicating the shares outstanding and confirming that Pacific Stock Transfer Company is
registered with the Securities and Exchange Commission.
5. This letter is governed by and shall be interpreted in accordance with the Legal Opinion
Accord (the “Accord”) of the American Bar Association Section of Business Law (1991).
Therefore, it is subject to a number of qualifications, exceptions, definitions, limitation on
coverage, and other limitations, all as more particularly described in the Accord, and this letter
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 5 of 7
should be read in conjunction therewith. The law relevant to the opinions expressed herein is
limited to the laws of the United States of America.
Adequacy of Public Information
Based upon the foregoing and subject to the qualifications hereinafter set forth, we are of the
opinion that the initial Company Information and Disclosure Statement:
(i) constitutes “adequate current public information” concerning the securities of the
Issuer and “is publicly available” within the meaning of Rule 144(c)(2) under the
Securities Act of 1933;
(ii) includes all of the information that a broker-dealer would be required to obtain from
the Issuer to publish a quotation for the Securities under Rule 15c2-11 under the
Securities Exchange Act of 1934 (the “Exchange Act”);
(iii) complies as to form with the OTC Markets Group Guidelines for Providing
Adequate Current Information, which is available at:
http://www.otcmarkets.com/content/doc/Disclos...lines.pdf;
(iv) has been posted on the OTC Disclosure and News Service; and
(v) Pacific Stock Transfer is registered under the Securities and Exchange Act of 1934.
(vi) This letter may be relied on by OTC Markets, Inc. but may not be used or relied upon
by any other person for any other purpose whatsoever, without in each instance our prior
written consent. OTC Markets may publish this letter through OTC Disclosure and News
Service for viewing by the public or regulators.
Financial Reporting
Issuer’s financial statements are not audited. The person responsible for the preparation of the
financial
statements contained in the report for the annual periods identified herein is Ambrose O
Egbuonu, the Issuer’s CEO and President. Mr. Egbuonu was assisted in the preparation of the
Issuer’s financial statements by Mr. Frank I Igwealor, CPA, CMA, who has over twenty six
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 6 of 7
years of management accounting and finance or consulting experience with OTC companies
including more than fourteen years as senior management level such as CEO, CFO, Controller
and Manager of several public or OTC companies including experience preparing financial
reports for those public companies.
Transfer Agent
The Transfer agent for the Issuer is:
Pacific Stock Transfer
6725 Via Austi Pkwy Ste 300,
Las Vegas, NV 89119-3553
Telephone: 702-361-3033.
paul@pacificstocktransfer.com
The Transfer Agent is listed with the Commission and has Depository Trust Corporation
approval. For the year ending December 31, 2020, and period ended June 30, 2021, the Issuer
had 1,412,692,586 shares of Common Stock issued and outstanding. A shareholders list
provided by the Transfer Agent as of July 27, 2021, was cross-referenced with the other
information previously filed by the issuer with the OTC and provided to us by the Issuer to
determine the number of outstanding shares set forth in the Issuers Annual reports for the year
ended December 31, 2020 and 2019, and Quarterly reports for the period ended March 31, 2021,
and June 30, 2021.
SEC Investigation
The corporate office of the Issuer is located at 370 Amapola Ave., Suite200-A, Torrance, CA,
90501. Its website is still being developed and the phone number is (310) 895-1839.
The issuer was incorporated under the laws of the state of Nevada on December 18, 2008.
On July 07, 2021, the District Court of Clark County, Nevada entered an Order Granting
Application for Appointment of Alpharidge Capital, LLC (the “Order”), a company controlled
by Mr. Frank Igwealor, as Custodian of the Company. On July 07, 2021, the Custodian
appointed Mr. Ambrose O Egbuonu, who is affiliated to Alpharidge Capital, LLC., as the
Company’s sole officer, secretary, treasurer and director. Neither the new management nor the
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 7 of 7
OTC Markets Group, Inc.
300 Vesey Street, 12th Floor
New York, NY 10282
Re: Legal Opinion, Adequate Current Information, Continuing Disclosure Obligations of
JPX Global , Inc., a Nevada corporation (the “Issuer”) for the Annual Reports for Periods
Ending 12/31/2019 and 12/31/2020, and the Quarterly Reports for the Period Ending
03/31/2021 and 6/30/2021.
Ladies and Gentlemen:
This office has been engaged by JPX Global, Inc., a Nevada corporation, (the "Issuer"
as its general and securities counsel for matters including, but not limited to, the preparation of this
opinion.
This opinion may be posted on the OTC Disclosure and News Service for viewing by the general
public. OTC Markets Group, Inc. may rely on this opinion in determining whether the Issuer has
made adequate current information publicly available within the meaning of Rule 144(c)(2) of
the Securities Act of 1933, as amended.
This letter covers the laws of the United States and does not depend on another law firm’s
opinion or letter. The subject matter of this letter covers the jurisdiction of the State of Nevada
(the Issuer's state of incorporation) and the laws of the United States. Attorney Udo Ekekeulu
(hereinafter referred to as Counsel) is permitted to practice before the Securities and Exchange
Commission without prohibition. Counsel is licensed in the State of California and is a resident
of the State of California. Counsel is current in her membership requirements for the State of
California. Counsel is currently not, and has not within the past five years, been the subject of an
investigation, hearing, or proceeding by the SEC, the US Commodity Futures Trading
Commission, (CFTC), the Financial Industry Regulatory Authority, (FINRA) or any other
federal, state, or foreign regulatory agency. Counsel is also currently not, and has not within the
past five years, been suspended or barred from practicing in any jurisdiction. She has not been
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 2 of 7
charged in a civil or criminal case. A representative of the Company is responsible for the
preparation of the financial statements in accordance with GAAP, under the supervision of the
CEO and is unaudited.
Counsel is not an employee of the Issuer and Counsel has received no shares of the Issuer’s stock
in payment for Counsel’s services. Furthermore, Counsel does not have any current agreements
to receive, whether now or in the future, any shares of Issuer common stock as compensation for
preparation of this opinion or for any other services. Counsel does not own, directly or
beneficially, any shares of the Issuer’s Securities.
Counsel has been retained by the Issuer for the purpose of reviewing the current information
supplied by the Issuer and has also been retained as outside counsel for other matters. Counsel
has examined such corporate records and other documents and such questions of law as counsel
considers necessary or appropriate for the purposes of rendering this letter.
For purposes of this opinion counsel has reviewed the
1. Articles of Incorporation and Amendments of the Articles of Incorporation of the Issuer,
2. Corporate By-Laws,
3. Information, as defined below
4. And such other corporate records as were necessary and provided by management for
purposes of this letter, including press releases and past and current financial statements and
have examined such corporate records and other documents and such questions of law as counsel
considered necessary or appropriate for purposes of rendering the letter.
We have (i) personally interviewed via phone conference the management and all directors of the
Company, more specifically Ambrose O Egbuonu, CEO, President, Treasurer, the CourtAppointed Custodian, Frank I Igwealor, and all owners of 5% or greater of the outstanding stock
including Frank I Igwealor, however, we’re not able to contact, meet or interview persons who
were associated with prior management (this shell was purchased from a custodial management),
(ii) reviewed the annual financials ended December 31, 2020 and filed with the OTC disclosure
News Service on www.OTCmarkets.com and posted on October 02, 2021, reviewed the annual
financials ended December 31, 2019 and filed with the OTC disclosure News Service on
www.OTCmarkets.com and posted on October 02, 2021, reviewed the quarterly financials ended
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 3 of 7
March 31, 2021 and filed with the OTC disclosure News Service on www.OTCmarkets.com and
posted on October 02, 2021, reviewed the quarterly financials ended June 30, 2021 and filed with
the OTC disclosure News Service on www.OTCmarkets.com and posted on October 02, 2021,
and (iii) discussed the information with management and the director(s) of the Company.
To the best of our knowledge, after inquiry of management, including the sole Chief Executive
Officer and Director, neither the Issuer, the 5% holders of securities of the Company, nor the
corporate counsel are currently under investigation by any federal or state regulatory authority
for any violation of federal or state securities laws. There are no other family relationships or
related party transactions with JPEX to disclose in its filings or in the Attorney letter. The
company has not received any request for information or inquiries of any kind from the SEC or
FINRA and are unaware of any request or inquiries from the SEC or FINRA since January 31,
2018. There are no pending corporate actions.
The opinion and conclusions herein are based upon documentation and facts made available by
the Issuer and are based on the accuracy of those documents and facts. All such information is
believed to be true and such sources of information are believed to be reliable. As to matters of
fact, counsel relied on information obtained from public officials, officers of the Issuer and other
sources, and believed such information to be true and such sources of information are believed to
be reliable. If the facts and information in all such documents are determined not to be true, this
opinion shall be null and void.
We may rely on information obtained from public officials, officers of the Company and we
believe that these sources are reliable. In rendering this letter, we have examined the following:
1. Corporate records and other documents of the company.
Financial documents including: Balance Sheet, Statement of Operations, Statement of Cash
Flows, Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in
Shareholder Equity) and notes to the financial statements for the year ending December 31,
2020, uploaded to the OTC disclosure News Service on www.OTCmarkets.com and posted on
October 02, 2021; Balance Sheet, Statement of Operations, Statement of Cash Flows,
Consolidated Statements of Stockholder’s Deficiency (Statement of Changes in Shareholder
Equity) and notes to the financial statements for the year ending December 31, 2019, uploaded to
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 4 of 7
the OTC disclosure News Service on www.OTCmarkets.com and posted on October 02, 2021;
Balance Sheet, Statement of Operations, Statement of Cash Flows, Consolidated Statements of
Stockholder’s Deficiency (Statement of Changes in Shareholder Equity) and notes to the
financial statements for the quarter ending March 31, 2021, uploaded to the OTC disclosure
News Service on www.OTCmarkets.com and posted on October 02, 2021; and Balance Sheet,
Statement of Operations, Statement of Cash Flows, Consolidated Statements of Stockholder’s
Deficiency (Statement of Changes in Shareholder Equity) and notes to the financial statements
for the quarter ending June 30, 2021, uploaded to the OTC disclosure News Service on
www.OTCmarkets.com and posted on October 02, 2021. We may rely on information obtained
from public officials, officers of the Company and we believe that these sources are reliable.
2. Issuer’s financial statements are not audited. The person responsible for the preparation of the
financial
statements contained in the report for the annual periods identified herein is Ambrose O
Egbuonu, the Issuer’s CEO and President. Mr. Egbuonu was assisted in the preparation of the
Issuer’s financial statements by Mr. Frank I Igwealor, CPA, CMA, who has over twenty six
years of management accounting and finance or consulting experience with OTC companies
including more than fourteen years as senior management level such as CEO, CFO, Controller
and Manager of several public or OTC companies including experience preparing financial
reports for those public companies. His address is 370 Amapola Ave., Suite 200-A, Torrance,
CA 90501, Tel. 310-895-1839.
3. Representations made to us by the sole officer and director of the Company which we deem as
reliable.
4. Review of the Shareholders’ list provided by the Company’s transfer agent: Pacific Stock
Transfer Company of 6725 Via Austi Pkwy., Ste. 300, Las Vegas, NV 89119, Tel. 702-581-
8475, indicating the shares outstanding and confirming that Pacific Stock Transfer Company is
registered with the Securities and Exchange Commission.
5. This letter is governed by and shall be interpreted in accordance with the Legal Opinion
Accord (the “Accord”) of the American Bar Association Section of Business Law (1991).
Therefore, it is subject to a number of qualifications, exceptions, definitions, limitation on
coverage, and other limitations, all as more particularly described in the Accord, and this letter
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 5 of 7
should be read in conjunction therewith. The law relevant to the opinions expressed herein is
limited to the laws of the United States of America.
Adequacy of Public Information
Based upon the foregoing and subject to the qualifications hereinafter set forth, we are of the
opinion that the initial Company Information and Disclosure Statement:
(i) constitutes “adequate current public information” concerning the securities of the
Issuer and “is publicly available” within the meaning of Rule 144(c)(2) under the
Securities Act of 1933;
(ii) includes all of the information that a broker-dealer would be required to obtain from
the Issuer to publish a quotation for the Securities under Rule 15c2-11 under the
Securities Exchange Act of 1934 (the “Exchange Act”);
(iii) complies as to form with the OTC Markets Group Guidelines for Providing
Adequate Current Information, which is available at:
http://www.otcmarkets.com/content/doc/Disclos...lines.pdf;
(iv) has been posted on the OTC Disclosure and News Service; and
(v) Pacific Stock Transfer is registered under the Securities and Exchange Act of 1934.
(vi) This letter may be relied on by OTC Markets, Inc. but may not be used or relied upon
by any other person for any other purpose whatsoever, without in each instance our prior
written consent. OTC Markets may publish this letter through OTC Disclosure and News
Service for viewing by the public or regulators.
Financial Reporting
Issuer’s financial statements are not audited. The person responsible for the preparation of the
financial
statements contained in the report for the annual periods identified herein is Ambrose O
Egbuonu, the Issuer’s CEO and President. Mr. Egbuonu was assisted in the preparation of the
Issuer’s financial statements by Mr. Frank I Igwealor, CPA, CMA, who has over twenty six
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 6 of 7
years of management accounting and finance or consulting experience with OTC companies
including more than fourteen years as senior management level such as CEO, CFO, Controller
and Manager of several public or OTC companies including experience preparing financial
reports for those public companies.
Transfer Agent
The Transfer agent for the Issuer is:
Pacific Stock Transfer
6725 Via Austi Pkwy Ste 300,
Las Vegas, NV 89119-3553
Telephone: 702-361-3033.
paul@pacificstocktransfer.com
The Transfer Agent is listed with the Commission and has Depository Trust Corporation
approval. For the year ending December 31, 2020, and period ended June 30, 2021, the Issuer
had 1,412,692,586 shares of Common Stock issued and outstanding. A shareholders list
provided by the Transfer Agent as of July 27, 2021, was cross-referenced with the other
information previously filed by the issuer with the OTC and provided to us by the Issuer to
determine the number of outstanding shares set forth in the Issuers Annual reports for the year
ended December 31, 2020 and 2019, and Quarterly reports for the period ended March 31, 2021,
and June 30, 2021.
SEC Investigation
The corporate office of the Issuer is located at 370 Amapola Ave., Suite200-A, Torrance, CA,
90501. Its website is still being developed and the phone number is (310) 895-1839.
The issuer was incorporated under the laws of the state of Nevada on December 18, 2008.
On July 07, 2021, the District Court of Clark County, Nevada entered an Order Granting
Application for Appointment of Alpharidge Capital, LLC (the “Order”), a company controlled
by Mr. Frank Igwealor, as Custodian of the Company. On July 07, 2021, the Custodian
appointed Mr. Ambrose O Egbuonu, who is affiliated to Alpharidge Capital, LLC., as the
Company’s sole officer, secretary, treasurer and director. Neither the new management nor the
DocuSign Envelope ID: 81C5BB41-8108-4DC6-8FEE-64F84601B2FD
ALPHA ADVOCATE LAW GROUP PC.
11432 South Street Suite 373, Cerritos, CA 90703.
TEL: 562-219-0089. FAX: 562-456-3016.
EMAIL: Alphaadvocatelaw@gmail.com
___________________________________________________________________________________
JPEX - Attorney Letter with Respect to Current Information - All periods from 12.31.2019
through 06.30.2021.
Page 7 of 7
